EU to Investigate Zoetis Over Possible Breach of Competition Rules
Provided by
Dow Jones
By Ian Walker
The European Commission has started a formal investigation into animal health company Zoetis to see if it broke competition rules by preventing the launch of a competing pain medicine for dogs.
The European Commission--the EU's executive arm--said Tuesday that it plans to start an in-depth investigation as a matter of priority.
The company wasn't immediately available for comment when approached by Dow Jones Newswires.
Write to Ian Walker at ian.walker@wsj.com
(END) Dow Jones Newswires
March 26, 2024 09:54 ET (13:54 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
Undervalued by 25% and Yielding 5%, This Stock Is a Buy
-
Can AI Predict Future Stock Returns?
-
The Best Energy Stocks to Buy Now
-
10 Undervalued Wide-Moat Stocks
-
Obesity Drugs: Can New Firms Take Market Share From Eli Lilly and Novo Nordisk?
-
New 4-Star Stocks
-
Intel Fair Value Left Unchanged Despite Qualcomm Takeover Talk
United States